Navigating Commercialization with ApiJect Technology
- Gain knowledge of the Blow-Fill-Seal aseptic fill-finish process and its relevance to ApiJect technology.
- Identify the key factors to consider in a co-development program, including drug product stability, compatibility, and feasibility in the Prefilled ApiJect injector.
- Analyze the appropriate entry strategy for your drug product, considering factors such as product availability, existing data, and risk tolerance.
- Recognize the ApiJect Centers of Excellence in technology development (Florida), device development (North Carolia), and device design (London) as resources for advancing your drug product commercialization efforts.
Reserve a session for your team
What to Expect in this Online Lunch & Learn
Learn how to navigate commercialization using ApiJect technology. We will cover several key learning objectives, including gaining knowledge of the Blow-Fill-Seal aseptic fill-finish process and its relevance to ApiJect technology.
We will identify key factors to consider in a co-development program, including drug product stability, compatibility, and feasibility in the Prefilled ApiJect injector. It also analyzes the appropriate entry strategy for your drug product, considering factors such as product availability, existing data, and risk tolerance.
Additionally, we will discuss the ApiJect Centers of Excellence in technology development (Florida), device development (North Carolina), and device design (London) as resources for advancing your drug product commercialization efforts. Participants will gain a thorough understanding of how to navigate commercialization with ApiJect technology and effectively advance their drug product commercialization efforts.
The Prefilled ApiJect Injector* is the combination of two trusted technologies: BFS aseptic drug packaging process, and a pen needle-style needle hub.
Our approach is just one example of how we are creating prefilled injectors that work for everyone in all markets… that are easy to use, cost effective, and more environmentally friendly.
ApiJect has product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
Navigating Commercialization with ApiJect Technology
- Gain knowledge of the Blow-Fill-Seal aseptic fill-finish process and its relevance to ApiJect technology.
- Identify the key factors to consider in a co-development program, including drug product stability, compatibility, and feasibility in the Prefilled ApiJect injector.
- Analyze the appropriate entry strategy for your drug product, considering factors such as product availability, existing data, and risk tolerance.
- Recognize the ApiJect Centers of Excellence in technology development (Florida), device development (North Carolia), and device design (London) as resources for advancing your drug product commercialization efforts.